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Abstract 
Background: Anti-dsDNA antibodies play an important role in the pathogenesis of lupus nephritis (LN). Endoplasmic 
reticulum (ER) stress is a physical reaction under stressful condition and can cause inflammation when stimulation 
is sustained. This study investigated the roles of ER stress in anti-dsDNA antibody-induced inflammation response in 
human mesangial cells (HMCs).
Method: Anti-dsDNA antibodies isolated from LN patients were used to stimulate HMCs. The expression of GRP78, 
PERK, p-PERK, p-eIF2α, ATF4, p-IRE1α, ATF6 and CHOP in HMCs was measured by western blot. NF-κB activation was 
detected by examining nuclear translocation of NF-κB p65. The expression and production of IL-1β, TNF-α and MCP-1 
were examined by qPCR and ELISA.
Results: Flow cytometry and cellular ELISA showed that anti-dsDNA antibodies can bind to HMCs. The binding was 
not inhibited by blockage of Fc receptor. Anti-dsDNA antibody stimulation significantly enhanced the expression of 
GRP78, p-PERK, p-eIF2α and ATF4 in HMCs. However, no significant increase in the expression of p-IRE1α and ATF6 
was found. In addition, anti-dsDNA antibodies also significantly increased the activation of NF-κB and upregulated 
the expression of IL-1β, TNF-α and MCP-1, which were suppressed by pretreatment of HMCs with chemical ER stress 
inhibitor 4-PBA. Transfection of specific ATF4 siRNA also significantly reduced the activation of NF-κB and expression 
of proinflammatory cytokines.
Conclusion: Anti-dsDNA antibodies induce NF-κB activation and inflammation in HMCs via PERK-eIF2α-ATF4 ER 
stress pathway.
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Background
Systemic lupus erythematosus (SLE) is an autoimmune 
disease characterized by production of auto-antibodies 
[1]. Kidney is one of the most frequently involved organs 
in SLE. Deposition of auto-antibodies in the kidneys 
triggers inflammation resulting in lupus nephritis (LN), 
which may progress to end-stage renal failure [2].
Anti-double-stranded DNA (anti-dsDNA) antibodies 
are the hallmark auto-antibodies in SLE and correlated 
with disease activities of LN [3]. Previous study showed 
that monoclonal anti-dsDNA antibody stimulated the 
expression and release of inflammatory cytokines from 
normal human mononuclear cells [4]. Anti-dsDNA anti-
bodies can also bind to human mesangial cell (HMCs) 
and cause inflammation [5]. However, the specific patho-
genesis of anti-dsDNA antibodies in LN remains unclear.
Endoplasmic reticulum (ER) is recognized as a site for 
biosynthesis, folding, assembly, modification and degra-
dation of proteins in the state of physiology [6]. ER stress 
is defined as accumulation of unfolded or misfolded 
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proteins in the ER lumen. When the demand for ER func-
tion is over its capacity, ER stress arises [7]. In respond 
to ER stress, unfolded protein response (UPR) path-
way was activated to prevent such accumulation in the 
ER lumen to cope with the stressful conditions [8, 9]. It 
is now recognized that three ER-localized transmem-
brane signal transducers including protein kinases IRE1 
(inositol-requiring kinase 1), PERK (double-stranded 
RNA-activated protein kinase-like ER kinase), and the 
transcription factor ATF6 (activating transcription fac-
tor 6) can be activated to initiate adaptive responses 
in response to ER stress [10]. PERK is one of the three 
localized transmenbrane transducers. Released from Bip, 
PERK homodimerization and phosphorylation can phos-
phorylate eIF2α. The phosphorylation of eIF2α subse-
quently activates the transcription factor ATF4. At last, 
ATF4 induces the expression of UPR target genes, which 
are involved in oxidative stress response and inflamma-
tion [11].
Accumulating evidences indicate that ER stress has a 
close relation with inflammation and autoimmunity [12, 
13]. NF-κB is a key transcription factor that has a central 
role in the initiation of inflammation [14]. NF-κB remains 
in cytoplasm in an inactive state and translocates into 
the nucleus once activated, inducing the transcription 
of numerous inflammation-associated genes [15]. It has 
been reported that NF-κB can be activated in response 
to ER stress [16], implying that ER stress might cause 
inflammation through activating NF-κB. In addition, the 
activation of NF-κB is involved in the pathogenesis of 
glomerulonephritis, including LN [17]. Extensive upregu-
lation of NF-κB in renal tubular and interstitial cells was 
observed in LN [18].
It has been demonstrated that ER stress played impor-
tant roles in glomerular and tubular damages in kidney 
diseases [19]. In experimental models of membranopro-
liferative glomerulonephritis and membranous nephrop-
athy, ER stress has been described in glomerular cells 
[20]. However, the roles of ER stress in LN remained 
undefined. In this report, we demonstrated that anti-
dsDNA antibodies from LN patients bound to HMCs, 
inducing ER stress and activated NF-κB through PERK-
eIF2α-ATF4 ER stress pathway.
Methods
Patients and isolation of polyclonal anti‑dsDNA antibodies 
or healthy serum IgG
Anti-dsDNA antibodies-positive sera were obtained 
from renal biopsy-proven active diffuse proliferative 
LN patients. Serum anti-dsDNA antibody level was 
measured and 10  serum samples with a concentration 
of anti-dsDNA antibody ≥4  IU/ml were used for this 
study. A concentration of 0–0.9  IU/ml was recognized 
as negative in this assay. The patient demographics were 
listed in Table 1. Twenty healthy sera were used as con-
trols. Serum was  obtained with informed consent with 
prior approval from the Institutional Ethical Committee 
of First Affiliated Hospital, Sun Yat-sen University. Poly-
clonal anti-dsDNA antibodies were isolated from sera of 
lupus patients and IgG was isolated from healthy subjects 
by affinity chromatography as previously described [21]. 
Immune complexes were removed from blood samples by 
polyethylene glycol precipitation before isolation. Serum 
samples were diluted with PBS to 1:1. Native DNA-cel-
lulose column (GE Biotech, USA) was equilibrated with 
25 mM Tris buffer (pH 8.0) at a flow rate of 0.5 ml/min 
and the diluted serum sample was added to the col-
umn. Non-DNA-binding fractions were flushed with the 
above buffer, and anti-DNA antibodies were eluted with 
a linear NaCl gradient. The columns were subsequently 
washed with 20 mM Tris–HCl (pH 7.4) containing 2 M 
NaCl, 1 mM ethylene diamine tetra acetic acid (EDTA), 
and 1  mM β-mercaptoethanol before further elution. 
IgG were then isolated with protein G Sepharose affin-
ity chromatography kits (GE Biotech, USA), desalted and 
concentrated to 20-fold using ultrafree-4 centrifugal fil-
ter units (Millipore, USA). The purity of eluted IgG was 
confirmed by 10% sodium dodecyl sulfate–polyacryla-
mide gel electrophoresis. A NanoDrop spectrophotom-
eter (Thermo Scientific, USA) was used to measure DNA 
level and no DNA contamination was detected in the iso-
lated anti-dsDNA antibodies or control IgG.
Cell culture
HMCs (Science II, USA) were cultured in RMPI1640 cul-
ture medium containing 10% fetal bovine serum (FBS). 
Cells were maintained at 37°C in 5% CO2 in a humidi-
fied cell culture incubator. The media were changed 
every other day. HMCs were used for all experiments 
Table 1 Patient demographics
F female, M male, SLEDAI systemic lupus erythematosus disease activity index 
and anti-dsDNA anti-double strand DNA antibodies.
Patients Age Sex SLEDAI Anti‑dsDNA(IU/ml)
1 46 F 18 5.3
2 36 F 16 4.7
3 43 F 18 5.2
4 24 M 22 4.2
5 52 F 21 4.8
6 26 F 17 4.6
7 18 F 20 5.3
8 27 F 22 5.9
9 36 F 16 4.6
10 28 F 18 4.7
Page 3 of 11Zhang et al. J Transl Med  (2015) 13:178 
when cultured up to 90% confluence and incubated with 
serum-free medium for up to 12  h prior to use. Cells 
were plated in 60 mm culture dishes and stimulated with 
100 nM of thapsigargin (TG, Sigma, USA), 10 μg/ml of 
anti-dsDNA antibodies, 10 μg/ml of normal human IgG, 
or medium alone for selected duration. In some experi-
ments, 10  mM of 4-PBA (Sigma, USA) was included. 
The number of viable cells was assessed by trypan blue 
(trypan blue exclusion >90%).
Detection the binding of anti‑dsDNA antibodies to HMCs 
by flow cytometry
HMCs were grown up to 90% confluence and harvested. 
Cells (1  ×  106) were incubated with 20  μg/ml of anti-
dsDNA antibodies from LN patients or IgG from healthy 
control at 4°C for 30  min, with or without blocking Fc 
receptors with anti-CD16/CD32/CD64 antibodies before 
incubation. After washed twice, cells were stained with 
FITC-conjugated  anti-human IgG antibody (Abclonal, 
USA) at 4°C for 30 min. Cells were washed, resuspended 
in 500 μl staining buffer and analyzed by flow cytometry.
Measurement of the binding of anti‑dsDNA antibodies 
to HMCs by cellular ELISA
HMCs were seeded in 96-well culture plates until 90% 
confluence. Cells were fixed with 4% formaldehyde at 
room temperature for 10 min and blocked with 5% BSA 
at 37°C for 30  min. Then the cells were incubated with 
hydrogen peroxide solution at room temperature for 
30  min. Cells were incubated with 20  μg/ml of anti-
dsDNA antibodies from LN patients or IgG from healthy 
control at 4°C overnight, with or without blocking Fc 
receptors with anti-CD16/CD32/CD64 antibodies before 
incubation. Cells were washed and incubated with anti-
human horseradish peroxidase conjugated-antibody for 
30  min at room temperature. After washing, cells were 
incubated with o-phenylenediamine (OPD) and OD val-
ues were determined at 450 nm.
Transfection
HMCs were plated in 60-mm dishes, cultured until 50% 
confluence and transfected with 40  nM ATF4 siRNA 
(Ruibo-bio, China) complexed with Lipofectamine 2000 
(Invitrogen, USA) in 500 μl Opti-MEM I Reduced-Serum 
Medium (Invitrogen, USA) at 37°C in a CO2 incubator. In 
control experiments, cells were transfected with 40  nM 
of negative control siRNA complexed with Lipofectamine 
2000. After 6  h of incubation, the RNAi-Lipofectamine 
complex was removed, and the cells were cultured over-
night in 1640 supplemented with 10% FBS. Twenty-four 
hours after transfection, cells were grow-arrested for 12 h 
and maintained with serum-free medium for 24 h prior 
to use. Then HMCs were incubated with 10 μg/ml anti-
dsDNA antibodies for 24 h.
Western blot analysis
Proteins were extracted from HMCs and separated by 
10% SDS–polyacrylamide gels. Nuclear and cytoplasmic 
proteins were extracted by using a nuclear protein extrac-
tion kit (Pierce, USA) according to the manufacture’s 
instructions. Then the proteins were electrotransferred 
onto polyvinylidinedifluoride membranes. After blocking 
with 5% bovine serum albumin in TBST, the membranes 
were incubated with anti-GRP78 (Novus, USA), anti-
p-PERK (Cell Signaling Technology, USA), anti-PERK 
(Santa, Cruz, USA), anti-ATF4 (Santa Cruz, USA), anti-
p-eIF2α (Cell Signaling Technology, USA), anti-eIF2α 
(Santa Cruz, USA), anti-IRE1α (Abcam, Hongkong), 
anti-ATF6 (Santa Cruz, USA), anti-CHOP (Santa Cruz, 
USA), anti-GAPDH (Kangcheng, China) primary anti-
bodies at 4°C overnight. Nuclear protein was used to 
measure NF-κB p65 (Santa Cruz, USA) in the nucleus. 
Anti-fibrillarin (Santa Cruz, USA) was used as control. 
The membranes were then washed with TBST and incu-
bated with horseradish peroxidase conjugated anti-rabbit 
IgG or anti-mouse IgG (Cell Signaling Technology, USA) 
at room temperature for 60 min, washed with TBST and 
the signal was detected by enhanced chemiluminescence 
(ECL). Band density was measured by densitometry with 
image J software.
qPCR
Total RNA was extracted from cultured cell using Trizol 
Reagent (Invitrogen, USA). RNA was reverse-transcribed 
into cDNA using the revert transcriptase (Fermentas, 
USA). cDNA was amplified in a PCR reaction using 
recombinant Taq DNA polymerase (Fermentas, USA). 
The following primers for human MCP-1, TNF-α, IL-1β 
and GAPDH were used: MCP-1: 5′-GAT CTC AGT GCA 
GAG GCT CG-3′ (forward), 5′-TGC TTG TCC AGG 
TGG TCC AT-3′ (reverse), TNF-α: 5′-CCC AGG GAC 
CTC TCT CTA ATC A-3′ (forward), 5′-GCT ACA GGC 
TTG TEA CTC GG-3′ (reverse), IL-1β: 5′-CGT CAG 
TTG TTG TGG CCA T-3′ (forward), 5′-GCG TGC AGT 
TCA GTG ATC GTA-3′ (reverse), GAPDH:5′-GAA GGT 
GAA GGT CGG AGT C-3′ (forward), 5′- GAA GAT 
GGT GAT GGG ATT TC-3′ (reverse). SYBR green-based 
quantitative real-time PCR were performed in triplicate 
in a Bio-Rad IQ5. The cDNA were denatured at 95°C for 
10 min and 35 cycles at 95°C for 15  s, 60°C for 1  min. 
Results of comparative real-time PCR were analyzed 
using IQ5  Software (Bio-Rad, USA). GAPDH was per-
formed as an intracellular control to confirm the quantity 
of RNA.
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ELISA
HMCs were incubated with 10 μg/ml anti-dsDNA anti-
bodies or control IgG for up to 48  h, after which the 
supernatant was collected and centrifuged at 2,000 rpm 
for 10  min to remove cell debris. The levels of IL-1β, 
MCP-1 and TNF-α in each sample were measured using 
commercial ELISA kits (Raybiotech, USA) according to 
the manufacturer’s instructions.
Statistical analyses
The results are expressed as the mean ±  SD. Statistical 
analysis was performed using SPSS 13.0. The differences 
were assessed by t test, or one way ANOVA with or with-
out repeated measurements followed by Bonferroni’s 
multiple comparison post test as appropriate. Two-tailed 
p < 0.05 was considered statistically significant.
Results
Anti‑dsDNA antibodies bound to HMCs
Flow cytometry showed that anti-dsDNA antibodies 
bound to HMCs, while healthy control IgG from healthy 
individuals did not bind to HMCs (Figure 1a). To clarify 
the binding mechanism of anti-dsDNA antibodies to 
HMCs, Fc receptors on HMCs were blocked with anti-
CD16/CD32/CD64 antibodies before incubated with 
anti-dsDNA antibodies. The binding of anti-dsDNA 
antibodies to HMCs was not inhibited by Fc receptor 
blocking (Figure 1a). The binding capacity of anti-dsDNA 
antibodies to HMCs was further confirmed by cellular 
ELISA (Figure 1b).
Anti‑dsDNA antibodies induced the activation of PERK ER 
stress pathway in HMCs
To study the effects of anti-dsDNA antibodies on HMCs, 
cells were cultured with anti-dsDNA antibodies (10 μg/
ml), control IgG or TG (100 nM) for 24 h. Cells viability 
was assessed by trypan blue (trypan blue exclusion >90%). 
The expression of ER stress specific protein GRP78 was 
significantly up-regulated in HMCs stimulated with ER 
stress inducer thapsigargin (Figure  2a). Anti-dsDNA 
antibodies significantly enhanced the expression of 
GRP78, p-PERK, p-eIF2α, and ATF4 in HMCs compared 
to control IgG (Figure  2a, c). Semi-quantificative analy-
sis showed significantly higher expression of GRP78, 
p-PERK, p-eIF2α, and ATF4 in HMCs stimulated with 
anti-dsDNA antibodies compared to cells incubated with 
control IgG (Figure 2b, d–f).
Anti‑dsDNA antibodies did not induce the activation 
of IRE1α and ATF6 ER stress pathways in HMCs
HMCs were incubated with anti-dsDNA antibodies, con-
trol IgG or TG for 24 h. Neither anti-dsDNA antibodies 
nor control IgG increased the expression of p-IRE1α and 
ATF6 in HMCs (Figure  3a). Semi-quantificative analy-
sis showed no significant difference in the expression of 
p-IRE1α and ATF6 between HMCs stimulated with anti-
dsDNA antibodies and cells incubated with control IgG 
(Figure  3b, c). Thapsigargin significantly increased the 
expression of CHOP in HMCs, but anti-dsDNA antibod-
ies did not significantly increase the expression of CHOP 
in HMCs compared to control IgG (Figure 3d, e).
Figure 1 Anti-dsDNA antibodies bind to HMC. a HMCs were incubated with anti-dsDNA antibodies or control IgG, washed and stained with FITC 
conjugated anti-human IgG, with or without Fc receptor blocking. Flow cytometry analysis showed that the binding of anti-dsDNA antibodies to 
HMCs was not inhibited by Fc receptor blocking. b HMCs were incubated with anti-dsDNA antibodies or control IgG, washed and stained with HRP-
conjugated anti-human IgG, with or without Fc receptor blocking. The binding of anti-dsDNA antibodies to HMCs was measured by cellular ELISA. 
No significant decrease in binding was observed after Fc receptor blocking. All experiments were repeated for three times. Data was expressed as 
mean ± SD, *P < 0.05 versus control IgG. CTL Control, anti-dsDNA Abs anti-dsDNA antibodies, and FcR  Fc receptor.
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Anti‑dsDNA antibodies activated NF‑κB and up‑regulated 
inflammation in HMCs
The expression NF-κB p65 was significantly increased 
in the nuclear extract of HMCs treated with thapsi-
gargin, indicating that ER stress can induce the acti-
vation of NF-κB. Similarly, anti-dsDNA antibodies 
induced the nuclear translocation of NF-κB p65 in 
HMCs (Figure  4a). However, there was no signifi-
cant increase in translocation of NF-κB p65 in HMCs 
stimulated with control IgG. The anti-dsDNA antibod-
ies also significantly enhanced the gene expresses of 
IL-1β, TNF-α, MCP-1 (Figure 4c–e) and promoted the 
secretion of IL-1β, TNF-α and MCP-1 in supernatants 
(Figure 4f–h).
Figure 2 Anti-dsDNA antibodies induce ER stress in HMC. HMCs were seeded in 6-well culture plate and stimulated with anti-dsDNA antibodies for 
24 h. a The expression of GRP78 was analyzed by western blot and b the relative expression of GRP78 was significantly increased when HMCs were 
stimulated with TG or anti-dsDNA antibodies. c HMCs were stimulated with anti-dsDNA antibodies for 24 h and the expression of p-PERK, p-eIF2α 
and ATF4 were analyzed by western blot. d–f Semi-quantificative analysis showed significant increase in the expression of p-PERK, p-eIF2α and 
ATF4. All experiments were repeated for three times. Data were expressed as mean ± SD, *P < 0.05, versus control media; #P < 0.05, versus control 
IgG. CTL Control, anti-dsDNA Abs anti-dsDNA antibodies and TG thapsigargin.
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Chemical chaperone inhibited anti‑dsDNA 
antibody‑induced ER stress in HMCs
HMCs were exposed to anti-dsDNA antibodies for 24 h. 
An ER stress inhibitor, the chemical chaperone 4-PBA, 
was included in some of the experiments. The expres-
sion of ATF4 in HMCs stimulated with anti-dsDNA anti-
bodies was significantly inhibited by 4-PBA (Figure  5a). 
NF-κB p65 nuclear translocation in HMCs stimulated 
with 4-PBA was also significantly inhibited by 4-PBA 
(Figure  5b). Furthermore, 4-PBA treatment resulted in 
significant reduction in the expression of IL-1β, TNF-α 
and MCP-1 mRNA (Figure 5e–g) and their secretions in 
supernatants (Figure 5h–j).
Anti‑dsDNA antibodies induced the activation of NF‑κB 
in HMCs via PERK‑eIF2α‑ATF4 pathway
HMCs were transfected with siRNA specific for ATF4 
or control siRNA. The depletion of ATF4 was confirmed 
by western blot analysis (Figure  6a). Specific depletion 
of ATF4 suppressed the nuclear translocation of NF-κB 
p65 induced by anti-dsDNA antibodies (Figure  6b). In 
addition, depletion of ATF4 significantly reduced anti-
dsDNA antibody-induced expression of IL-1β, MCP-1 
and TNF-α (Figure  6d–f), as well as the secretion of 
IL-1β, MCP-1 and TNF-α in the supernatant of HMCs 
(Figure 6g–i).
Discussion
This study demonstrated that anti-dsDNA antibodies 
can bind to HMCs and result in NF-κB activation and 
increased the expression of pro-inflammatory cytokines 
through the  induction of ER stress. The anti-dsDNA 
antibody-induced inflammation in HMCs was mediated 
through the PERK-eIF2α-ATF4 ER stress pathway.
Although anti-dsDNA antibodies are believed to be 
involved in the pathogenesis of LN, how they deposit 
and elicit inflammation in the glomeruli is not fully eluci-
dated. Early study showed that a monoclonal anti-dsDNA 
Figure 3 IRE1α and ATF6 pathways were not activated by anti-dsDNA antibodies in HMCs. HMCs were stimulated with anti-dsDNA antibodies for 
24 h. a The expression of p-IRE1α and ATF6 were measured by western blot. b, c Semi-quantitative analysis showed no significant changes in the 
expression of p-IRE1α and ATF6. d The expression of CHOP was measured by western blot. e TG treatment significantly increased the expression of 
CHOP but no significant up-regulation of CHOP was found in MHCs stimulated with anti-dsDNA antibodies. All experiments were repeated for three 
times. Data were expressed as mean ± SD, *P < 0.05, versus control media. CTL Control, anti-dsDNA Abs anti-dsDNA antibodies and TG thapsigargin.
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antibody PME77 bound to a number of human cell types: 
erythrocytes, neuroblastoma, a T-lymphoblastoid cell 
line (HSB2), a B-lymphoblastoid cell line (Ramos) and 
normal T and B lymphocytes [22]. Subsequent study 
revealed that anti-dsDNA antibody bind to cell surface 
protein via nuceleosomes or a DNA-histone complexs 
in human fibroblast CVI cells [23]. In human mesan-
gial cells (HMCs), affinity-purified polyclonal anti-DNA 
antibodies from patients with SLE can bind to cultured 
HMCs [21], which was mediated though annexin II [5]. 
It is interesting to note that the binding of anti-DNA 
antibodies to HMC was increased after the removal of 
Ig-associated DNA by DNase treatment, but it was unaf-
fected by DNase treatment of HMC membrane [21]. 
These suggest a direct binding of anti-dsDNA antibod-
ies to HMC rather than mediation through DNA or 
DNA-histone complex. In the present study, binding of 
anti-dsDNA antibodies to HMCs was confirmed by flow 
cytometry and by cellular ELISA. In addition, blocking 
of Fc receptor did not affect the binding of anti-dsDNA 
antibodies to HMCs, indicating that anti-dsDNA anti-
bodies bind to HMCs via Fab fragments.
Figure 4 Anti-dsDNA antibodies activated NF-κB and caused inflammation in HMCs. HMCs were stimulated with anti-dsDNA antibodies. a NF-κB 
p65 was measured by western blot analysis of the nuclear protein extract. b Anti-dsDNA antibodies significantly increased nuclear translocation of 
NF-κB p65 compared to control IgG. c–e Anti-dsDNA antibodies significantly increased the expression of IL-1β, MCP-1 and TNF-α mRNA as meas-
ured by qPCR. f–h Anti-dsDNA antibodies also significantly increased the secretion of IL-1β, MCP-1 and TNF-α in supernatants as measured by ELISA. 
All experiments were repeated for three times. Data were expressed as mean ± SD, *P < 0.05, versus control media, #P < 0.05, versus control IgG. 
CTL Control, anti-dsDNA Abs anti-dsDNA antibodies and TG thapsigargin.
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Figure 5 Chemical chaperone inhibited ER stress induced by anti-dsDNA antibodies in HMCs. a, b HMCs were stimulated with anti-dsDNA anti-
bodies. The expression of ATF4 and nuclear translocation of NF-κB p65 were measure by western blot. c, d 4-PBA significantly inhibited the expres-
sion of ATF4 and the nuclear translocation of NF-κB p65 induced by anti-dsDNA antibodies. e–g 4-PBA significantly inhibited the expression of 
IL-1β, MCP-1 and TNF-α mRNA as measured by qPCR. h–j 4-PBA significantly inhibited the secretion of IL-1β, MCP-1 and TNF-α in the supernatants 
as measured by ELISA. All experiments were repeated for three times. Data were expressed as mean ± SD, *P < 0.01, versus control media, #P < 0.01, 
versus anti-dsDNA antibodies group. CTL Control and anti-dsDNA Abs anti-dsDNA antibodies.
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ER stress has been reported to be associated with 
chronic inflammatory or autoimmune diseases including 
diabetes and obesity, neurodegenerative and neuromus-
cular inflammatory diseases, and inflammatory bowel 
diseases [24–26]. ER stress is also observed in renal 
inflammation [27, 28]. In a rat anti-Thy1 mesangiopro-
liferative nephritis, there was an increase in the expres-
sion of the ER stress-inducible chaperones GRP78 and 
oxygen-related protein 150 in isolated glomeruli, espe-
cially in the glomerular epithelial cells and mesangial 
cells, after the induction of the disease [29]. In human 
primary glomerulonephritis (GN), there was pronounced 
increased expression of GRP78 in proliferative GN com-
pared to non-GN, suggesting that ER stress pathway 
might be involved in the progression of GN [30]. The role 
of ER stress in lupus nephritis (LN) is still not clear. It 
has been shown that homocysteine-induced ER protein 
(Herp), an ER stress-inducible protein, was able to bind 
to anti-dsDNA antibodies [31], and was a potential trig-
gering antigen for anti-DNA response [32], implying that 
anti-dsDNA antibodies have a functional connection 
with ER stress in the pathogenesis of LN. In this study, 
we found that stimulation of HMCs with anti-dsDNA 
antibodies resulted in significantly increased expres-
sion of GRP78 and increased expression of inflammatory 
cytokines IL-1β, MCP-1 and TNF-α. These results sug-
gest that anti-dsDNA antibodies can elicit proinflamma-
tory response in HMC via inducing ER stress.
Figure 6 Anti-dsDNA antibodies induced NF-κB activation via PERK-eIF2α-ATF4 ER stress pathway. a Depletion of ATF4 by ATF4 siRNA was 
confirmed by western blot. b HMCs were stimulated with anti-dsDNA antibodies. NF-κB p65 nuclear translocation was measured by western blot 
analysis of nuclear protein extract. c ATF4 siRNA significantly inhibited NF-κB p65 nuclear translocation induced by anti-dsDNA antibodies. d–f ATF4 
siRNA significantly inhibited the expression of IL-1β, MCP-1 and TNF-α mRNA as measured by qPCR. g–i ATF4 siRNA also significantly inhibited the 
secretion of IL-1β, MCP-1 and TNF-α in supernatants as measured by ELISA. All experiments were repeated for three times. Data were expressed as 
mean ± SD, *P < 0.01, versus control group, #P < 0.01, versus scramble siRNA group. CTL Control and anti-dsDNA Abs anti-dsDNA antibodies.
Page 10 of 11Zhang et al. J Transl Med  (2015) 13:178 
The ER stress response consists of three transmem-
brane signal transducers including protein kinase IRE1, 
PERK and the transcription factor ATF6 [10]. Our results 
showed that the ER stress inducer thapsigargin can acti-
vate all three pathways. In contrast, anti-dsDNA antibod-
ies only significantly activate PERK and its downstream 
molecules, eIF2α and ATF4. There were no significant 
changes in the expression of p-IRE1α or ATF6, indicating 
anti-dsDNA antibodies elicit ER stress in HMCs through 
PERK pathway only. The reason for such a discrepancy 
is not clear. It is postulated that anti-dsDNA antibod-
ies might bind to the membrane molecule that activates 
PERK ER stress pathway specifically.
NF-κB, a major transcription factor in regulating 
inflammatory processes, is involved in the pathogen-
esis of LN. Inhibition of NF-κB resulted in ameliorated 
inflammation in the mouse LN model [33]. It has been 
shown that ER stress induces the activation of NF-κB 
[34–36]. ER stress inducers including thapsigargin and 
tunicamycin increase the activity of NF-κB as well as 
NF-κB-dependent gene expression [37]. PERK and eIF2α 
were reported to be involved in the activation of NF-κB 
and the phosphorylation of PERK and eIF2α were in 
accordance with the activation of IKK/NF-κB [36]. This 
implies that PERK pathway might play an important role 
in the activation of NF-κB. In the present study, anti-
dsDNA antibodies induced the activation of ER stress 
accompanied with the activation of NF-κB and up-reg-
ulation of IL-1β, TNF-α and MCP-1. Inhibition of ER 
stress in HMCs with chemical chaperon 4-PBA reduced 
the activation of NF-κB and the expression of IL-1β, 
TNF-α and MCP-1. In addition, specific depletion of 
ATF4 significantly reduced the activation of NF-κB and 
the expression of proinflammatory cytokines. These indi-
cate that anti-dsDNA antibodies activate NF-κB in HMC 
via inducing ER stress.
The activation of CHOP in ER stress is recognized to 
be involved in cell apoptosis [38]. However, CHOP can 
also be activated by ATF4 and increase the production of 
inflammatory cytokines [39]. These raise the the possibil-
ity that the upregulation of proinflammatory cytokines 
induced by anti-dsDNA antibodies in HMCs is the result 
of CHOP activation rather than through NF-κB activa-
tion. However, inhibition of ER stress by chemical chap-
eron or the specific ATF4 silencing did reduce NF-κB 
activation, suggesting a cross talk between ER stress 
signaling pathway and NF-κB activation. Indeed, ATF4 
is involved in the activation of NF-κB in macrophage 
induced by saturated fatty acids [40]. The activation of 
NF-κB was significantly decreased in ATF4 haploinsuffi-
ciency macrophage [40]. On the other hand, our results 
showed that anti-dsDNA antibodies did not induce the 
expression of CHOP. This study provides new evidences 
that anti-dsDNA antibodies activate NF-κB and cause 
inflammation in HMCs via PERK-eIF2α-ATF4 ER stress 
pathway.
Conclusions
This study demonstrated that anti-dsDNA antibodies 
induce NF-κB activation and enhanced expression of pro-
inflammatory cytokines in HMCs via PERK-eIF2α-ATF4 
ER stress pathway. ER stress response may be involved in 
the development or progression of LN initiated by anti-
dsDNA antibodies.
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